Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Regen BioPharma Inc

CIK 1589150 RGBP·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Auditor change 8-K
  2. Late filing NT 10-Q +29d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing Filing comparison

Regen BioPharma Inc told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed 1 day before the statutory due date.

Evidence
Anticipates significant change
No
Days past due date
-1
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Auditor change SEC item code

Regen BioPharma Inc reported a change in its independent accounting firm

The company dismissed the auditor. Simon & Edward LLP → not stated No disagreements disclosed.

Evidence
Direction
dismissed
Direction label
The company dismissed the auditor
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Predecessor auditor
Simon & Edward LLP
Predecessor tier
other
Severity
normal
Source
SEC 8-K item code
Tier downgrade
No
Why
The company's independent registered accounting firm changed.

Source filing ↗